This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the potential of anti-CD19 CAR T Cells for the treatment of myasthenia gravis.
Ticker(s): CABA, KYTXWho's the expert?
Institution: Wayne State University
- Assistant Professor in Neurology and Director of the Residency training program at Wayne State University.
- Manages 500 patients with Multiple sclerosis.
- Specializes in autoimmune neurological disorders including NMOSD, MOG antibody disease, Neurosarcoidosis, Myasthenia Gravis, Chronic inflammatory demyelinating polyneuropathy (CIDP), paraneoplastic disorders, and the neurologic complications of systemic autoimmune disorders such as Lupus and Sjogren's Syndrome.
Interview GoalThis call will feature a discussion on the current therapies being developed for treating Myasthenia gravis including CD-19 CAR-T cell Therapies
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
